Navigation Links
Pharma Industry Group Favors Obama as Next President
Date:4/24/2008

FLORHAM PARK, N.J., April 24 /PRNewswire-USNewsire/ -- Showing solid, and surprising, support among pharmaceutical industry marketers, Democratic candidate for president Sen. Barack Obama emerged as the candidate-to-beat following a mock election held during last week's annual DTC National Conference in Washington, D.C. The annual gathering discusses issue of direct-to-consumer drug advertising, now one of the largest advertising categories.

Senator Obama "defeated" both his leading rivals in the mock elections held during the conference's opening session. The victory marked a surprising outcome for Obama, who came out on top in an industry known for backing Republican candidates in recent elections.

Obama won a "primary" vote against Sen. Hillary Rodham Clinton (D-N.Y.) by a wide margin (59% to 40%) among the marketers, agency executives and service suppliers in the direct-to-consumer prescription drug advertising sector. In a second voting round against presumed Republican nominee Sen. John McCain, Obama also won convincingly, taking a 53% to 46% victory over the Arizona senator.

"Given the Republican leanings of the drug industry, it is somewhat surprising to see Barack Obama so handily defeat John McCain," said Bob Ehrlich, chief executive of DTC Perspectives. "Of course, that could be an indication that McCain's frequent anti-industry comments have made him unpopular with drug company marketers. Or, it could reflect that drug industry marketers do not vote with their employer interests as their primary concern."

In a separate vote by conference delegates, 61% of the marketers said they expected additional regulations on DTC to be approved by year's end or by early 2009. The group also was pessimistic about the direction of ad spending, with 35% expecting a reduction in advertising budgets and 36% saying that budgets would not change in the current year. Fewer than one in three (28%) said they expected DTC budgets to increase i
'/>"/>

SOURCE DTC Perspectives, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Stronger-Than-Ever Generic Threat Forces Big Pharma to Be Creative
2. Miami Jury Convicts Pharmacy Owner of Medicare Fraud
3. Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R)
4. Pharma Base S.A. Launches Osamine(TM) Pharmaceutical Grade Glucosamine in North America
5. Prime Hires Rachelle Wan as Vice President of Pharmaceutical Trade Relations
6. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
7. Pharmacyclics Reports Third Quarter 2008 Financial Results
8. Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved Guidelines
9. Jazz Pharmaceuticals to Present at Morgan Stanley Conference
10. Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website
11. Medco, UnitedHealth Group Announce Pharmacy Services Agreement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...-- The National Cancer Institute has awarded a $55...son Cancer Research Center to become the nation,s ...ntact Center. ,, The move will create 60 new jo...size of its current CIS workforce - once the conso...duled for March 15, 2010. The Seattle CIS center w...
(Date:12/4/2009)...ogress has been made over the last 15 years in the...eat epilepsy and its complications. Yet this prog...f the 50 million people around the world, includin...nited States who have the disorder, , According ...rican Epilepsy Society (AES), there is an enormous...
(Date:12/4/2009)...mp; Author and Political Analyst Leslie Sanchez pr...ng Providence Hospital’s “Adopt-a-Fami...ise $5000 in cash and toy donations for the charit...ll match the donation. Toys will be distributed to...spital. , Washington, DC...
(Date:12/4/2009)...commend its use, experts say , , , FRID...aucoma patients and others can benefit from medica...can help multiple sclerosis (MS) patients find rel...f the debilitating autoimmune disease. , "The t... to be comprehensive, and should be given consider...
(Date:12/4/2009)...RNewswire-FirstCall/ -- Genomic Health, Inc. (Nasd...present results from five studies at the 32nd Annu...king place December 9-13, 2009, at the Henry B. Go...lyze Onco type DX®, the company,s multi-gene...predict the likelihood of chemotherapy benefit as ...
Breaking Medicine News(10 mins):Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 4Health News:Bobby Berk Home and Leslie Sanchez Announce 1st Annual Toy Drive for DC's Neediest Families 2Health News:Review Finds Marijuana May Help MS Patients 2Health News:Review Finds Marijuana May Help MS Patients 3Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 2Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 3Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 4
... 21 The Generic,Pharmaceutical Association (GPhA)...President and CEO Kathleen Jaeger regarding the Fe...ng Health Care Competition and Consumer Issues." ,...and,affordable biogenerics sooner rather than late...
...e University of Texas M. D. Anderson Cancer Cent...to eradicate breast cancer in Panama through the P...h of the Americas today at an event with Laura Bus...are the U.S. Department of State and Susan G. Kome...
... 21 U.S. News & World Report and the National...eChoice(R) HealthPlan of South Carolina in the top...ed in U.S. News & World Report,s issue this we...cores. NCQA and U.S. News & World Report ranke...
...r drugs do not cause genetic damage that can lead ...News) -- Two popular medications for treating atte... cause genetic damage linked to an increased risk ...nters a previous one that reported biomarkers asso...
...PRNewswire/ -- For the second year in a row and ...althcare Worldwide,s agency network won more creat...nd annual international RX Club Show. , , Ni...thcare Worldwide agencies include Caudex Medical, ...
...co use is more prevalent and smoking cessation les...ractivity Disorder (A.D.H.D.) In a study of smoke...ms, those who exhibited elevated hyperactivity and....D. symptoms. The study, now available online in ...
Other Medicine News:Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2
(Date:12/4/2009)... , HOUSTON, Dec. 4 OrthoAccel T...ystem , which is an acceleration device to enhance... Continuing Education course published by PennWel... for many industries, including medicine and denti...rthodontic treatment, a summary of treatment biome...
(Date:12/4/2009)... Md., Dec. 4 Drs. Neal Shore and E...ecific antigen (PSA) recurrence from the additiona...recurrence rate in a Phase III pivotal study of FI...monthly leuprolide in prostate cancer patients dur...patients who received FIRMAGON 240/80 mg/month had...
(Date:12/4/2009)... N.J., Dec. 4 Depression, anxiety ...ractivity Disorder (ADHD), sleep disorder and migr...o occur more often in people who said they had bee...epilepsy diagnosis, according to a survey of appro...Findings from " CNS-Related Comorbidities in Indiv...
Breaking Medicine Technology:AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Advanced Life Sciences Restanza Demonstrates Efficacy in Treating Anthrax Infection 55707 1Advanced Life Sciences Restanza Demonstrates Efficacy in Treating Anthrax Infection 55707 2Advanced Life Sciences Restanza Demonstrates Efficacy in Treating Anthrax Infection 55707 3Advanced Life Sciences Restanza Demonstrates Efficacy in Treating Anthrax Infection 55707 4Advanced Life Sciences Restanza Demonstrates Efficacy in Treating Anthrax Infection 55707 5Vitality Health LLC Joins HealthySkinPortal Network 55704 1Vitality Health LLC Joins HealthySkinPortal Network 55704 2Foldaway Pediatric Point of Care Table Provides Efficient Work Surface Without Compromising Space 55701 1Foldaway Pediatric Point of Care Table Provides Efficient Work Surface Without Compromising Space 55701 2
... Against Difficult-to-Treat Skin Infections...tant Staphylococcus aureus (MRSA), NEW YORK, June... announced positive results from two globally cond...e, a broad-spectrum,cephalosporin with activity ag...m negative bacteria, for the treatment of complica...
... using cloned cells alone ... describe the first,successful use of a human pati...e therapy to put an advanced solid-tumor cancer in... M.D., an associate member of the,Clinical Researc...er,reports these findings in the June 19 issue of ...
Other Medicine Technology:Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 2Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 3Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 4Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation 2Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation 3
Premier Lock 'n Roll Drainable Pouch, Pre-Sized Convex Flextend Skin Barrier, with Tape
Premier Lock 'n Roll Drainable Pouch with Filter, Cut-to-Fit SoftFlex Skin Barrier
Premier High Output Pouch Non-Sterile
Premier Closed Pouch with Filter, Cut-to-Fit SoftFlex Skin Barrier
Medicine Products: